Iradimed declares $0.20 quarterly dividend, reaffirms guidance
Iradimed announced a $0.20 per share quarterly dividend and affirmed its 2026 revenue and earnings forecasts. The company also reported somewhat flat quarterly revenue due to supply constraints of its new IV pump but noted strong order bookings.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day